All results / Stories
Irvine's Allergan Inc., the specialty drug maker, is eyeing the market for prescription acne medications with its Tazorac cream.
HEALTHCARE: Trim to market cap means more potential suitors
The field of potential Big Pharma suitors for Irvine-based Allergan Inc. could widen in the wake of the company’s stock price drop over the past few months.
Buy of Digital Company Deepens Social Efforts
Irvine-based Alphaeon Corp. is continuing to grow its healthcare technology presence.
Says Study Reinforces Jeuveau Performance
Evolus Inc. is (almost) ready for its close-up.
HEALTHCARE: Drug maker buying dermatology companies
Valeant is buying up skin drug companies
Cyvatar, the developer of a subscription-based cybersecurity software management platform, raised $3 million from Austin-based Bill Wood Ventures on Oct. 6.
Can $3B Drug, Other Aesthetics Salve Restasis Pain?
The market has not been kind to Allergan PLC (NYSE: AGN) following the failure of its September deal in which the pharmaceutical company transferred all patents for dry-eye drug Restasis to the Saint Regis Mohawk Tribe in New York.
2017 Sales Up Almost 6%, Though Club Lost Members
2017 was another good year to be one of Orange County’s largest women-owned businesses.
MARKETING: Apps, messaging, Cancún trips
Forget the frown lines, it was all smiles last week inside the Newport Center headquarters of Botox rival maker Evolus Inc. (Nasdaq: EOLS).
Rex Bright is following in the footsteps of his former employer, Irvine-based Allergan Inc.
Irvine-based Cohere, a software platform for customer-facing employees, recently closed a $3.1 million seed round of financing led by Initialized Capital.